<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005168</url>
  </required_header>
  <id_info>
    <org_study_id>1042</org_study_id>
    <secondary_id>R01HL031497</secondary_id>
    <nct_id>NCT00005168</nct_id>
  </id_info>
  <brief_title>Hyperapo B and Coronary Heart Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart, Lung, and Blood Institute (NHLBI)</source>
  <brief_summary>
    <textblock>
      To determine the role of apolipoprotein B and apolipoprotein A1 in the etiology of coronary
      artery disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      Hyperapo B is a phenotype defined as elevated plasma level of the major apoprotein B of low
      density lipoproteins in the presence of a normal plasma level of low density lipoprotein
      cholesterol. It has been demonstrated that hyperapo B is strongly associated with coronary
      artery disease. In 1984 when the study began, the independence of this association with other
      risk factors for coronary artery disease such as cigarette smoking, hypertension, and low
      plasma levels of high density lipoproteins was not known. The study improved knowledge of the
      pathophysiology of coronary artery disease and of the genetic and biochemical defects of
      hyperapo B and hypoalphalipoproteinemia.

      DESIGN NARRATIVE:

      Interviews were conducted and clinical data collected on each index case and spouse, as well
      as on first degree relatives. Risk factor data included blood pressure, blood lipid levels,
      obesity, cigarette smoking, fasting blood sugar and diabetes, hormone use and menopause for
      women, physical activity, personality scores, and family history. Clinical data included the
      indications for coronary arteriography, history of use of lipid-lowering agents and insulin,
      presence of corneal arcus, xanthomata, and xanthelasma, and the electrocardiogram.

      To determine if the apolipoprotein B gene and the apolipoprotein A1-C3-A4 gene cluster were
      independent predictors of premature coronary disease, the relation between DNA polymeric
      sites within the two genes and coronary disease were investigated using cloned DNA fragments
      as molecular probes. To determine if apolipoprotein B and apolipoprotein A levels aggregated
      in families and to determine if hyperapo B and hypoalphalipoproteinemia segregated as
      Mendelian traits, genetic analysis was conducted in the 200 index cases and the 900 first
      degree relatives. Studies were also conducted on the linkages between hyperapo B and
      haplotypes of the apolipoprotein B gene, on hyperapo B and the Ag polymorphisms, and on
      hyperalphalipoproteinemia and haplotypes of the apolipoprotein A1-C3-A4 gene cluster.

      The study completion date listed in this record was obtained from the &quot;End Date&quot; entered in
      the Protocol Registration and Results System (PRS) record.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 1984</start_date>
  <completion_date type="Actual">December 1991</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Cardiovascular Diseases</condition>
  <condition>Coronary Disease</condition>
  <condition>Heart Diseases</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Obesity</condition>
  <condition>Hypercholesterolemia, Familial</condition>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO Jr. Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis. 1984 Mar-Apr;4(2):79-83. Review.</citation>
    <PMID>6422918</PMID>
  </reference>
  <reference>
    <citation>Sniderman A, Teng B, Genest J, Cianflone K, Wacholder S, Kwiterovich P Jr. Familial aggregation and early expression of hyperapobetalipoproteinemia. Am J Cardiol. 1985 Feb 1;55(4):291-5.</citation>
    <PMID>3969864</PMID>
  </reference>
  <reference>
    <citation>Teng B, Sniderman A, Krauss RM, Kwiterovich PO Jr, Milne RW, Marcel YL. Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses. J Biol Chem. 1985 Apr 25;260(8):5067-72.</citation>
    <PMID>2580831</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich PO Jr, Bachorik PS, Franklin FA Jr, Margolis S, Georgopoulos L, Teng B, Sniderman AD. Effect of dietary treatment on the plasma levels of lipids, lipoprotein cholesterol and LDL B protein in children with type II hyperlipoproteinemia. Prog Clin Biol Res. 1985;188:123-37.</citation>
    <PMID>4059254</PMID>
  </reference>
  <reference>
    <citation>Beaty TH, Kwiterovich PO Jr, Khoury MJ, White S, Bachorik PS, Smith HH, Teng B, Sniderman A. Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia. Am J Hum Genet. 1986 Apr;38(4):492-504.</citation>
    <PMID>3706300</PMID>
  </reference>
  <reference>
    <citation>Genest J, Sniderman A, Cianflone K, Teng B, Wacholder S, Marcel Y, Kwiterovich P Jr. Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load. Arteriosclerosis. 1986 May-Jun;6(3):297-304.</citation>
    <PMID>3707428</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich P, Beaty T, Bachorik P, Chen J, Franklin F, Georgopoulos L, Sniderman A. Pediatric hyperlipoproteinemia: the phenotypic expression of hyperapobetalipoproteinemia in young probands and their parents. Prog Clin Biol Res. 1988;255:89-105.</citation>
    <PMID>3340649</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich PO Jr, White S, Forte T, Bachorik PS, Smith H, Sniderman A. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis. 1987 May-Jun;7(3):211-25.</citation>
    <PMID>3593067</PMID>
  </reference>
  <reference>
    <citation>Sniderman A, Kwiterovich PO Jr: Hyperapobetalipoproteinemia and LDL and HDL2 Heterogenity. Proceedings of the Workshop on Lipoprotein Heterogeneity, U.S. Department of Health and Human Services, NIH Publication No. 87-2646, pp 293-304, 1987</citation>
  </reference>
  <reference>
    <citation>Beaty TH, Kwiterovich PO, Laville A, Lewis B. Genetic analysis of total cholesterol and triglycerides in a pedigree of St. Thomas rabbits. J Lipid Res. 1989 Mar;30(3):387-94.</citation>
    <PMID>2723545</PMID>
  </reference>
  <reference>
    <citation>Ma YH, Ladias JA, BÃ¼tler R, Schumaker VN, Antonarakis SE, Lusis AJ, Heinzman C, Kwiterovich PO. Apolipoprotein B gene haplotypes. Association between Ag and DNA polymorphisms. Arteriosclerosis. 1988 Sep-Oct;8(5):521-4.</citation>
    <PMID>2461193</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich PO Jr. Biochemical, clinical, genetic and metabolic studies of hyperapo-beta-lipoproteinaemia. J Inherit Metab Dis. 1988;11 Suppl 1:57-73. Review.</citation>
    <PMID>3141687</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich PO Jr. HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. Clin Chem. 1988;34(8B):B71-7. Review.</citation>
    <PMID>3042202</PMID>
  </reference>
  <reference>
    <citation>Bachorik PS, Kwiterovich PO Jr. Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays. Clin Chim Acta. 1988 Nov;178(1):1-34. Review.</citation>
    <PMID>3067911</PMID>
  </reference>
  <reference>
    <citation>Ladias JA, Kwiterovich PO Jr, Smith HH, Miller M, Bachorik PS, Forte T, Lusis AJ, Antonarakis SE. Apolipoprotein B-100 Hopkins (arginine4019----tryptophan). A new apolipoprotein B-100 variant in a family with premature atherosclerosis and hyperapobetalipoproteinemia. JAMA. 1989 Oct 13;262(14):1980-8.</citation>
    <PMID>2778934</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich PO. Genetic influences on susceptibility to atherosclerosis in the young. Bull N Y Acad Med. 1989 Dec;65(10):1092-108; discussion 1154-60. Review.</citation>
    <PMID>2698247</PMID>
  </reference>
  <reference>
    <citation>Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HF, Kwiterovich PO Jr, Pearson TA. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol. 1990 Nov;16(6):862-70.</citation>
    <PMID>2146310</PMID>
  </reference>
  <reference>
    <citation>Ladias JA, Kwiterovich PO Jr, Smith HH, Karathanasis SK, Antonarakis SE. Apolipoprotein A1 Baltimore (Arg10----Leu), a new ApoA1 variant. Hum Genet. 1990 Apr;84(5):439-45.</citation>
    <PMID>2108924</PMID>
  </reference>
  <reference>
    <citation>Beaty TH, Prenger VL, Virgil DG, Lewis B, Kwiterovich PO, Bachorik PS. A genetic model for control of hypertriglyceridemia and apolipoprotein B levels in the Johns Hopkins colony of St. Thomas Hospital rabbits. Genetics. 1992 Dec;132(4):1095-104.</citation>
    <PMID>1459430</PMID>
  </reference>
  <reference>
    <citation>Prenger VL, Beaty TH, Kwiterovich PO. Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catheterization patients. Am J Hum Genet. 1992 Nov;51(5):1047-57.</citation>
    <PMID>1415250</PMID>
  </reference>
  <reference>
    <citation>Coresh J, Beaty TH, Kwiterovich PO Jr, Antonarakis SE. Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels. Am J Hum Genet. 1992 May;50(5):1038-45.</citation>
    <PMID>1570833</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich PO Jr, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol. 1992 Apr 15;69(12):1015-21.</citation>
    <PMID>1561971</PMID>
  </reference>
  <reference>
    <citation>Heizmann C, Kirchgessner T, Kwiterovich PO, Ladias JA, Derby C, Antonarakis SE, Lusis AJ. DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet. 1991 Apr;86(6):578-84.</citation>
    <PMID>1673959</PMID>
  </reference>
  <reference>
    <citation>Miller M, Bell W, Plano S, Connors J, Kennedy S, Kwiterovich P. Platelet aggregation in hyperapobetalipoproteinemia. Am J Hematol. 1991 Jul;37(3):209-11.</citation>
    <PMID>1858776</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich PO Jr, Motevalli M, Miller M, Bachorik PS, Kafonek SD, Chatterjee S, Beaty T, Virgil D. Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III. Clin Chem. 1991 Mar;37(3):317-26. Review.</citation>
    <PMID>2004437</PMID>
  </reference>
  <reference>
    <citation>Kwiterovich P Jr, Motevalli M, Miller M. Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8980-4.</citation>
    <PMID>2247473</PMID>
  </reference>
  <reference>
    <citation>Miller M, Kwiterovich PO Jr. Isolated low HDL-cholesterol as an important risk factor for coronary heart disease. Eur Heart J. 1990 Dec;11 Suppl H:9-14. Review.</citation>
    <PMID>2073916</PMID>
  </reference>
  <verification_date>May 2000</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2000</study_first_submitted>
  <study_first_submitted_qc>May 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2000</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2016</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Hyperlipoproteinemia Type II</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

